OCUL
Ocular Therapeutix, Inc. (OCUL)
Last Price$8.511.2%
Market Cap$1,347.5M
1Y Forward Revenue growth
11.7%
1Y Forward EPS growth
2.9%
Last EPS & EPS Surprise
($0.29)
14.2% miss
Last 10 Earnings
4 Beat / 6 Miss

OCUL Revenue and EPS Expectations

Annual
Quarterly

Revenue

Dec'22Dec'23Dec'24Dec'25Dec'26Dec'27Dec'28Dec'29$51.5M$58.4M$63.7M$71.2M$81.8M$149.4M$359.6M$734.9M
Revenue actual
Revenue estimate

EPS

Dec'22Dec'23Dec'24Dec'25Dec'26Dec'27Dec'28Dec'29($0.83)($1.09)($1.22)($1.21)($1.26)($0.99)($0.23)$1.41
EPS actual
EPS estimate
Dec'22Dec'23Dec'24Dec'25Dec'26Dec'27Dec'28Dec'29
Revenue growth18.3%13.5%9.0%11.7%14.9%82.6%140.6%104.4%
EPS growth492.9%31.3%11.9%2.9%3.9%(21.3%)(76.9%)N/A

OCUL Earnings Surprises

Crunching data... Almost there!

OCUL Earnings History

Mar'15Jun'15Sep'15Dec'15Mar'16Jun'16Sep'16Dec'16Mar'17Jun'17Sep'17Dec'17Mar'18Jun'18Sep'18Dec'18Mar'19Jun'19Sep'19Dec'19Mar'20Jun'20Sep'20Dec'20Mar'21Jun'21Sep'21Dec'21Mar'22Jun'22Sep'22Dec'22Mar'23Jun'23Sep'23Dec'23Mar'24Jun'24Sep'24Dec'24
Revenue actual$426.0K$459.0K$429.0K$436.0K$458.0K$441.0K$477.0K$511.0K$475.0K$438.0K$523.0K$487.0K$340.0K$648.0K$498.0K$504.0K$492.0K$650.0K$829.0K$2,256.0K$2,609.0K$1,569.0K$5,876.0K$7,349.0K$7,342.0K$11.7M$12.2M$12.3M$13.2M$12.3M$12.0M$14.1M$13.4M$15.2M$15.0M$14.8M$14.7M$16.4M$15.4M$17.1M
Revenue estimate$474.7K$474.7K$474.7K$474.7K$447.6K$447.6K$447.6K$447.6K$393.1K$393.1K$393.1K$393.1K$323.0K$323.0K$323.0K$323.0K$428.8K$738.4K$580.0K$2,195.0K$2,655.5K$1,498.8K$5,501.4K$7,730.2K$7,636.7K$10.8M$12.5M$13.9M$14.0M$14.2M$14.3M$13.5M$14.1M$14.6M$15.2M$15.7M$15.4M$15.8M$17.1M$17.2M
Revenue surprise10.3%3.3%9.6%8.1%2.3%1.5%6.6%14.2%20.8%11.4%33.0%23.9%5.3%100.6%54.2%56.0%14.7%12.0%42.9%2.8%1.8%4.7%6.8%4.9%3.9%8.2%2.4%11.7%5.5%13.9%16.2%4.0%5.1%3.8%1.8%5.7%4.2%3.7%9.9%0.4%
EPS actual($0.35)($0.45)($0.47)($0.43)($0.44)($0.46)($0.39)($0.52)($0.58)($0.64)($0.54)($0.44)($0.40)($0.37)($0.38)($0.42)($0.41)($0.57)($0.40)($0.54)($0.41)($0.64)($0.19)($1.21)$0.04($0.11)$0.03($0.07)($0.09)($0.21)($0.35)($0.15)($0.47)($0.26)($0.01)($0.35)($0.49)($0.26)($0.22)($0.29)
EPS estimate($0.43)($0.43)($0.43)($0.43)($0.42)($0.42)($0.42)($0.42)($0.38)($0.38)($0.38)($0.38)($0.36)($0.36)($0.36)($0.36)($0.41)($0.48)($0.51)($0.42)($0.37)($0.30)($0.24)($0.17)($0.21)($0.21)($0.26)($0.23)($0.23)($0.22)($0.24)($0.25)($0.26)($0.30)($0.29)($0.30)($0.19)($0.22)($0.24)($0.25)
EPS surprise18.6%4.7%9.3%0.0%4.8%9.5%7.1%23.8%52.6%68.4%42.1%15.8%11.1%2.8%5.6%16.7%0.0%19.4%21.1%28.6%10.8%113.3%21.5%626.0%119.4%47.6%111.5%69.1%62.4%5.4%46.9%40.8%78.5%13.7%97.7%18.1%154.5%17.5%9.4%14.2%

FAQ

1. What is Ocular Therapeutix, Inc. (OCUL) 1-year forward revenue growth estimate?

Ocular Therapeutix, Inc. (OCUL) 1-year forward revenue growth is estimated at 11.7%.

2. What is Ocular Therapeutix, Inc. (OCUL) 1-year forward EPS growth estimate?

Ocular Therapeutix, Inc. (OCUL) 1-year forward EPS growth is estimated at 2.9%.

3. What was Ocular Therapeutix, Inc. (OCUL) last EPS, and was there a surprise?

Ocular Therapeutix, Inc. (OCUL) last reported EPS was ($0.29), with a 14.2% miss.

4. What is Ocular Therapeutix, Inc. (OCUL) performance across the last 10 earnings reports?

Ocular Therapeutix, Inc. (OCUL) had 4 beats and 6 misses in its last 10 earnings reports.